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Background:The flagellum-related protein FliT and the ATP-dependent protease ClpXP negatively regulate the activity of
the flagellar master transcriptional regulator, FlhD4C2.
Results: FliT selectively enhances the ClpXP-dependent proteolysis of FlhC subunit of FlhD4C2.
Conclusion: FliT and ClpXP work concertedly to repress FlhD4C2 activity by enhanced degradation of FlhC subunit.
Significance: Enhancement of ClpXP-dependent proteolysis of FlhC by FliT is a novel example of regulated proteolysis.
We previously reported that the ClpXP ATP-dependent pro-
tease specifically recognizes and degrades the flagellar master
transcriptional activator complex, FlhD4C2, to negatively con-
trol flagellar biogenesis. The flagellum-related protein, FliT, is
also a negative regulator of flagellar regulon by inhibiting the
binding of FlhD4C2 to the promoter DNA. We have found a
novel pathway of FliT inhibition of FlhD4C2 activity connected
to ClpXP proteolysis. An in vitro degradation assay using puri-
fied proteins shows that FliT selectively increases ClpXP prote-
olysis of the FlhC subunit in the FlhD4C2 complex. FliT behaves
specifically to ClpXP-dependent proteolysis of FlhC. An in vitro
interaction assay detects the ternary complex of FliT-FlhD4C2-
ClpX. FliT promotes the affinity of ClpX against FlhD4C2 com-
plex, whereas FliT does not directly interact with ClpX. Thus,
FliT interacts with the FlhC in FlhD4C2 complex and increases
the presentation of the FlhC recognition region to ClpX. The
DNA-bound formofFlhD4C2 complex is resistant toClpXPpro-
teolysis. We suggest that the role of FliT in negatively control-
ling the flagellar gene expression involves increasing free mole-
cules of FlhD4C2 sensitive toClpXPproteolysis by inhibiting the
binding to the promoter DNA as well as enhancing the selective
proteolysis of FlhC subunit by ClpXP.
ClpXP is a member of the AAA proteases (the term AAA
comes fromATPases associated with diverse cellular activities)
that have important regulatory functions in bacterial cells by
adjusting the activity of key metabolic enzymes or limiting the
availability of critical regulatory proteins that control gene
expression (1, 2). The ClpP component of ClpXP consists of
two stacked heptameric rings, which enclose a central chamber
containing the 14 active sites of the peptidase (3). The ClpX
component is a hexameric ring ATPase that binds substrate
proteins, denatures them, and translocates the unfolded poly-
peptides into the ClpP degradation chamber (4). Substrate rec-
ognition is critical for the targeted degradation of regulatory
proteins whose level needs to be precisely controlled in cells. In
some instances, substrates are recognized directly by ClpXP by
a degradation tag (5). In other cases, which are called regulated
proteolysis, an accessory protein called an adaptor is required
to ensure efficient degradation (1, 6–8). Adaptor proteins
enhance or expand the substrate recognition of their cognate
proteases. For example, an adaptor protein, SspB, is present in
Escherichia coli (7). When E. coli cells encounter amino acid
starvation, translation stalls, and the generated truncated nas-
cent peptides are tagged. SspB binds to both SsrA-tagged pep-
tides and ClpX, thereby increasing the effective local con-
centration of these molecules. This adaptor-mediated
degradation would rescue ribosome stalling caused by amino
acid starvation.
We have recently reported that a Salmonella protein, YdiV,
which was initially identified as a negative regulator of flagellar
gene expression (9–11), accelerates ClpXP-dependent degra-
dation of FlhD4C2, a master transcriptional regulator that acts
at the apex of the transcriptionhierarchy of flagellar genes orga-
nized into three promoter classes. The data show that YdiV acts
as an adaptor protein binding the FlhD subunit and delivering
the FlhD4C2 complex to ClpXP protease for degradation (12).
YdiV interacts with FlhD4C2 complex bound to the specific
promoter DNA to release FlhD4C2 from the DNA-protein
complex (12). YdiV is the first example of dual function protein
that targets the transcriptional regulator for protease-depen-
dent degradation by releasing the previously bound regulator
protein from the DNA. Substrates identified for ClpXP prote-
olysis include many transcriptional activators with DNA bind-
ing activity, such as RpoS, CtrA, and FlhD4C2 (2, 13, 14). These
specifically and strongly bind to the promoter DNA to activate
transcription of their corresponding gene. It is therefore
assumed that the specific binding of DNA to substrate protein
may protect the protein fromClpXP proteolysis. Here we dem-
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onstrate that FlhD4C2 bound to the promoter DNA for class II
genes in the flagellar regulon is resistant to ClpXP-proteolysis.
A Salmonella protein FliT is a multifunctional protein that
regulates flagellar biogenesis. FliT functions as an anti-FlhD4C2
factor in transcriptional control (i.e. it inhibits the binding of
FlhD4C2 complex to the promoter DNAs of class II genes in
flagellar regulon, leading to the negative regulation of flagellar
gene expression) (15). FliT is also an export chaperone specific
for the filament-capping protein FliD; it binds to FliD to pre-
vent its premature aggregation in the cytoplasm and control its
export (16, 17). FliT also associates with ATPases of flagellar
apparatus, FliI and FliJ (18).
In the present study, we demonstrate that FliT selectively
enhances the proteolysis of FlhC subunit in FlhD4C2 complex
by ClpXP. Our analyses show that FliT in vitro forms a ternary
complex of ClpX-FliT-FlhD4C2 through interactions with
ClpX and FlhD4C2 and between FliT and FlhC. We also show
that the DNA-bound form of FlhD4C2 is resistant to ClpXP-de-
pendent proteolysis. These findings indicate that the role of
FliT as an anti-FlhD4C2 factor for flagellar expression includes
(i) inhibition of FlhD4C2 binding to the promoter DNA, result-
ing in an increase of the form of FlhD4C2 sensitive to ClpXP-
proteolysis, and (ii) enhancement of selective proteolysis of the
FlhC subunit in the complexwithClpXP, decreasing the level of
functional FlhD4C2.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Media—Bacterial strains
and plasmids are listed in Tables 1 and 2 (12, 17, 19, 20). Bacte-
ria were grown in L broth (1% Bacto tryptone, 0.5% Bacto yeast
extract, 0.5% sodium chloride, pH 7.4) and L agar. When nec-
essary, the medium was supplemented with chloramphenicol
(20gml1) tetracycline (10gml1), ampicillin (25gml1),
kanamycin (25 g ml1), and spectinomycin (25 g ml1).
In Vivo Transcription of fliL Promoter—In vivo transcription
of the FlhD4C2-dependent fliL promoterwasmonitored using a
mini-Mu lac operon reporter MudJ (21). Transposition of
MudJ into the chromosome of SalmonellaTyphimurium strain
LT2 was performed as described, selecting for MudJ-encoded
kanamycin resistance (22). Selection plates also contained bac-
teriophage  (Chi), which kills flagellated cells (23) and pro-
vided a positive selection for MudJ insertions that had dis-
rupted flagellar genes. MudJ insertions were then subject to
complementation and DNA sequence analysis. Selection for 
resistance and flagellar gene complementation analysis was
performed as described (24). Complementation studies fol-
lowed by DNA sequence analysis of the fliL5100::MudJ allele
used here determined that theMudJ had inserted after the first
base of amino acid 97 in the fliL coding region and placed the
lac operon under the control of the fliL promoter.
Construction of Plasmids—To construct plasmid pHCX1
encoding His6-TEV-ClpX,3 the clpX gene was amplified from
the chromosome of strain 3306, using the primers clpX-
NheTEV-f (GGTATGGCTAGCGAAAACCTGTACTTC-
CAAATGACAGATAAACGCAAAG) and clpX-Xho-r (GCA-
GATCTCGAGTTATTCGCCAGAAGCCT). The fragment
generatedwas cleavedwithNheI at the 5 end andXhoI at the 3
end, and cloned into pTrcHisA. To construct plasmid pDHC1
encoding FlhD-His6-TEV site-FlhC, the flhD gene was ampli-
fied from the chromosome with flhD-Nco-f (CTTCCCCATG-
GGAACAATGCATACA) and flhD-Xho-r (CTAGACTCGA-
GTTATGCCCTTTTCTTACG). The fragment generated was
cleaved with NcoI at the 5 end and XhoI at the 3 end and
cloned into pTrcHisA. To generate the flhC-containing plas-




from the chromosome of the strain 3306. The fragment gen-
erated was cleaved withNdeI and XhoI and initially cloned into
pCold. The region of His6-TEV site-flhC on pCold was ampli-
fied by using the primers flhC-Xho-f (GCCATCTCGAGGAA-
AGGCGCACTTAATTATand flhC-Pst-r (GATCCCTGCAG-
TTAAACAGCCTGTTCGATC). The fragment generated was
cleavedwithXhoI at the 5 end andPstI at the 3 end and cloned
into pTrcHisA-FlhD constructed as described above.
Purification of ClpP, ClpX, FliT, and FlhD4-(His6FlhC)2
Complex—To purify ClpP, 1 liter of cultured E. coli DH5aZ1
derivative carrying pTKY610 (CS5123) was incubated at 37 °C
until the cells reached an A600 of 0.4. Isopropyl 1-thio--D-
galactopyranoside was added to a final concentration of 1 mM
for 3 h before the cells were collected by centrifugation. Cells
suspended in 50 ml of buffer A (50 mM Tris-HCl, pH 7.5, 150
mM KCl, 10% glycerol) were incubated on ice for 30 min. After
3 The abbreviations used are: TEV, tobacco etch virus; Ni-NTA, nickel-
nitrilotriacetic acid; ATPS, adenosine 5-O-(thiotriphosphate); BLI, biolayer
interferometry; ZBD, zinc-binding domain; AMP-PNP, 5-adenylyl-,-
imidodiphosphate.
TABLE 1
Bacterial strains used in this study
Unless designated otherwise, these strains were constructed during the course of
this study.










DH5Z1 DH5 lacIq Laboratory collection
CS5123 DH5Zl carrying pTKY610 Tomoyasu et al. (14)
CS6757 MC4100 clpPX::Cm flhDC::Km
CS6764 MC4100 clpPX-lon::Cm hslVU::Tc
carrying pHCX1
CS6828 DH5 carrying pGex6p1-FliT
CS6840 SG1146 clpP::Cm flhDC::Km
carrying pDHC1
CS6453 MC4100 lon clpPX/pProEX htb
GFP-ssrA
CS6530 DH5 carrying pTKY630
TABLE 2
Plasmids used in this study
Plasmid Relevant characteristics Reference or source
pTKY610 pUHE21–2fd12 carrying clpP gene, Ap Takaya et al. (12)
pHCX1 pTrcHisA carrying clpX gene This study
pTKY630 pZA4lacIq carrying ZBD (1–60)-clpX gene This study
pDHC1 pTrcHisA carrying flhD-His6-flhC gene This study
pGex6p1-fliT pGex6p-1 carrying fliT gene Imada et al. (17)
pUHE21–2fd12 PA1/lacO1 system vector, Ap Gamer et al. (19)
pProEx htb GFP-SsrA pProEx htb carrying gfp-ssrA Wojtyra et al. (20)
pZA4lacIq lacIq Sp Lab collection
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lysis by sonication, the supernatant after centrifugation was
loaded onto a HiTrap Q HP column (1 ml; GE Healthcare) and
washed with buffer A. The proteins were eluted with 20 ml of a
150–500 mM KCl linear gradient. The fractions containing
ClpPwere dialyzed into buffer B (50mMsodiumacetate, pH5.3,
1 mM DTT, 10% glycerol). The sample was loaded onto a
Resource S column (1 ml; GE Healthcare) and washed with
buffer B. The proteins were eluted with 20 ml of a 0–1000 mM
KCl linear gradient. The eluent was run on gel chromatography
using Superdex 200 10/300GL (24 ml; GE Healthcare) with
buffer C (50mMTris-HCl, pH 7.5, 1mMMgSO4, 1mMDTT, 40
mM NaCl, 10% glycerol).
To purify ClpX, 1 liter of a culture of E. coli MC4100,
clpXP-lon::Cm, hslUV::Tc carrying pHCX1 (CS6764) was
incubated at 37 °C until the cells reached anA600 of 0.4. Isopro-
pyl 1-thio--D-galactopyranoside was added to a final concen-
tration of 1 mM for 2 h before the cells were collected by cen-
trifugation. They were resuspended in 100 ml of buffer D (50
mM Tris-HCl, pH 7.5, 300 mM NaCl, 20 mM imidazole, 0.02%
Triton X-100, 20% glycerol) containing 2 tablets of Complete
EDTA-free protease inhibitor (Roche Applied Science). After
lysis by sonication, the supernatant collected following centri-
fugation was batch-bound to 1ml of Ni-NTA-agarose (Qiagen)
and washed with buffer D. Bound ClpX proteins were eluted
with buffer E (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 500 mM
imidazole, 0.02% Triton X-100, 20% glycerol). A one-twentieth
molar amount of His-TEV protein was added to the elution
fraction to remove the His-TEV cut site tag. The sample was
dialyzed against buffer F (50 mMHEPES-KOH, pH 7.5, 300 mM
NaCl, 20 mM imidazole, 0.02% Triton X-100, 20% glycerol) in a
cold room for 4 h. Fractions containing ClpX were run on gel
chromatography using Superdex 200 10/300GL (24 ml; GE
Healthcare) with buffer G (50 mM Tris-HCl, pH 7.5, 50 mM
NaCl, 1 mM DTT, 10% glycerol). For concentration, the frac-
tions containingClpXwere loaded ontoHiTrapQHP (1ml;GE
Healthcare) and washed with buffer H (50 mM Tris-HCl, pH
7.5, 50 mM NaCl, 1 mM DTT, 20% glycerol). The proteins were
eluted with 20 ml of a 0–1000 mM NaCl linear gradient. The
peak fractions of ClpX were collected and dialyzed against
buffer H.
To purify the FlhD4-(His6FlhC)2, 1 liter of a culture of E. coli
SG1146 clpP::Cm, flhDC::Km carrying pDHC1 (CS6840)
was incubated at 37 °C until the cells reached an A600 of 0.6.
Isopropyl 1-thio--D-galactopyranoside was added to a final
concentration of 1 mM for 3 h, and the cells were collected by
centrifugation. The pelleted cells were resuspended in 80 ml of
buffer I (50 mM NaHPO4, pH 8.0, 300 mM NaCl, 20 mM imida-
zole, 1 mM DTT) containing 2 tablets of complete-EDTA free
protease inhibitor (Roche Applied Science). After lysis by son-
ication, the supernatant collected by centrifugation was batch-
bound to a 1-ml slurry ofNi-NTAagarose (Qiagen) andwashed
with buffer I. Bound proteins were eluted with buffer I contain-
ing 250 mM of imidazole. The fractions containing FlhD4-
(His6FlhC)2 were dialyzed against buffer J (50 mM HEPES-
NaOH, pH 7.5, 50 mM NaCl, 1 mM DTT) and loaded onto
HiTrap heparin column (1 ml; GE Healthcare). The proteins
were eluted with 20 ml of a 0–1000 mM NaCl linear gradient.
To purify intact FlhD4C2, the His-TEV site tag was removed by
incubating withHis-TEV protease during dialysis in buffer J for
4 h and loaded onto a heparin column as described above. His-
GFP-SsrA was purified as described previously (20).
To purify FliT, 1-liter cultures of E. coli BL21, carrying the
plasmid pGex6p-1-GST-FliT, were grown to an A600 of 0.4,
induced by adding 1.0mM isopropyl 1-thio--D-galactopyrano-
side, incubated for 3 h, collected, and frozen. Thawed cells were
suspended to 40 ml of lysis buffer (50 mM Tris-HCl, pH 7.5 150
mM NaCl, 10% glycerol, 1 mM DTT) containing 1 tablet of pro-
tease inhibitor (Complete EDTA-free, Roche Applied Science).
The cells were lysed by sonication, and the lysate was centri-
fuged at 10,000  g for 20 min at 4 °C. The supernatant was
batch-bound to 1ml of pre-equilibrated GST-Sepharose 4FF as
slurry, and the sample was rotated for 20 min at 4 °C. After
centrifugation, the beads were washed twice with 5 ml of lysis
buffer. Bound GST-FliT was eluted in 1 ml of 20 mM reduced
glutathione-containing lysis buffer. To purify GST-FliT, the
eluted fraction was passed through a Superdex 200 10/300G
column equilibratedwith lysis buffer. For the purification of the
intact version of FliT, the eluted fraction was dialyzed with lysis
buffer containing 5 units of Precision protease overnight at
4 °C. The dialyzed sample was rebound to GST-Sepharose
beads, and the flow-through fraction was passed through a
HiTrap Q HP 1-ml column (equilibrated with buffer J and
eluted with a 0–1000 mM NaCl linear gradient).
In Vitro Degradation Assay—The degradation assay was car-
ried out in Clp assay buffer (25 mMHEPES, pH 7.6, 50 mM KCl,
10 mM MgCl2, and 1 mM DTT) using purified proteins. FlhD4-
(His6FlhC)2 complex was incubated with ClpX and ClpP at
37 °C in the presence or absence of 3mMATP. To see the effect
of FliT on the ClpXP proteolysis, a FlhD4-(His6FlhC)2 complex
or intact FlhD4C2 complex was preincubated with FliT for 3
min at 37 °C and then proteolyzed as above. A portion of the
reaction mixture was mixed with SDS-sample buffer and pro-
cessed on 16% SDS-PAGE and Coomassie Brilliant Blue
staining.
In Vitro Pull-down Assay—Purified FlhD4-(His6FlhC)2 (1
M) was batch-bound toNi-NTA resin in 100l of Clp binding
buffer with 10 mM imidazole (25 mM HEPES-KOH, pH 7.6, 50
mM KCl, 10 mM MgCl2, 5% glycerol, 1 mM DTT, 1 mM ATP, or
AMP-PNP, 10 mM imidazole). 0.1 M ClpX6 and 1 M FliT2
were preincubated with FlhD4-(His6FlhC)2 for 5 min. Bound
beads were washed twice with 500 l of Clp binding buffer.
ClpX and FliT bound to FlhD4-(His6FlhC)2 were coeluted with
500 mM imidazole-containing Clp assay buffer. A pull-down
assay with GST-Sepharose beads was used to detect ternary
complex of FliT-FlhD4C2-ClpX. 1M purified (GST-FliT)2 was
batch-bound to GST resin in 100 l of Clp binding buffer with
1 mM ATPS. 0.1 M ClpX6 and 1 M FlhD4-(His6FlhC)2 were
preincubated with GST-FliT for 5 min. Bound beads were
washed twice with 500 l of Clp assay buffer. ClpX and FlhD4-
(His6FlhC)2 bound to GST-FliT were coeluted with 100 mM
GSH-containing Clp assay buffer.
ATPase Assay—ATPase activity was measured according to
the colorimetric method of Lanzetta et al. (25) in 25 l of Clp
assay buffer. Samples contained 0.5 g of ClpX and 3 mMATP.
2.0 g of FlhD4C2, 0.5 g of ClpP, and 0.5 g of FliT, respec-
tively, were added to the samples when required. The reactions
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were stopped by the addition of 5 l of 500 mM EDTA. The
reaction mixture was mixed with 200 l of malachite green
mixture (3:1:1:1 volumes of water, 2 mM malachite green, 50
mM ammoniummolybdate, and 2.5% polyvinyl alcohol), and 25
l of 1 M sodium citrate. Absorption at 600 nm was measured
after 30 min of incubation at room temperature. Results were
compared with the calibration curve prepared for the phos-
phate salt.
Biolayer Interferometry (BLI) Analysis—To measure affinity
and kinetics of the interaction of FlhD4-(His6FlhC)2 and DNA,
a biolayer interferometry assay was done in an Octet RED96
instrument. Purified FlhD4-(His6FlhC)2 was captured on an Ni-
NTA sensor (ForteBio). Purified flhB promoter DNA was serially
diluted in Clp assay buffer and bound to captured FlhD4-
(His6FlhC)2.One-shotkineticsanalysiswasdonewithparallel sen-
sors, and a local Rmaxmodel was fitted to estimateKd and kon/koff.
The first 10 s of dissociation time is omitted from the curve fitting
analysis tominimize the buffer effect. To prepareDNA fragments
of FlhD4C2 binding site, the class II promoter region ranging from
226 to48 of the transcriptional start site of flhBwas amplified
by PCR (generated fragment size is 274 bp). To prepare unrelated
DNA fragment unbound to FlhD4C2 as a negative control, a DNA
fragment with similar sized 278-bp region is amplified from the
Salmonella genome using the following primers, neg-dna-f
(AAGGATCCGAAAACCTGTATTTTCAGATGAAACCTCT-
TCGCCAGCAAA) and neg-dna-r (TTTCTGCAGTTAG-
TCAGCGATTTCGTTTTCCTG).
RESULTS
FlhD4C2 Inhibition by FliT Is Partially Suppressed in ClpXP
Mutants—The overexpression of FliT inhibits motility and
transcription of flagellar genes (26). This effect has been shown
to be dependent on the binding of FliT to the FlhD4C2 complex
through the direct interaction with the FlhC subunit (17, 26).
We recently established that overexpression of YdiV promotes
degradation of FlhD4C2 in a ClpXP-dependent manner (12),
leading to decreasing flagellar gene expression. This ClpXP-
dependent effect of YdiV inhibition of flagellar genes transcrip-
tion appears to be contingent on the degree of expression of
YdiVbecause the expression of YdiV froma tetracycline-induc-
ible promoter (PtetA) inhibits transcription of FlhD4C2-depen-
dent gene expression in a ClpXP-dependent manner, yet the
expression of YdiV from a stronger arabinose promoter
(ParaBAD) inhibits FlhD4C2-dependent transcription in a
ClpXP-independent pathway (12). The ClpXP-independent
role of YdiV in suppressing gene expressionwas due to its inter-
action with FlhD4C2 bound to the class II promoter DNA to
release FlhD4C2 from the DNA-protein complex (12). We thus
investigated whether the effect of FliT on FlhD4C2-dependent
transcription of flagellar genes also involved the ClpXP path-
way. To test this hypothesis, the activity of a transcriptional
fusion to a class II flagellar gene, fliL, in a strain overexpress-
ing fliT under the control of ParaBAD in strain TH18233
(ParaBAD::fliT fliL::MudJ) wasmeasured. In the presence of the
arabinose inducer, overproduction of FliT resulted in inhibi-
tion of transcription of fliL, which appeared to be moderately
suppressed in the absence of ClpX because the FliT-dependent
inhibition of fliL transcriptionwas partially diminished, but not
abolished, in a clpX null mutant background (Table 3). This
suggests that the ClpXP pathway is involved in the FliT-depen-
dent inhibition of fliL transcription.
FliT Directly Accelerates the Degradation of FlhC Subunit in
FlhD4C2 Complex by ClpXP Protease—The finding that the
FliT-dependent inhibition of fliL transcription was suppressed
partially by clpXP mutation suggests that FliT might directly
enhance the degradation of FlhD4C2 by ClpXP. Thus, the
effects of FliT on the degradation of FlhD4C2 by ClpXP were
tested in vitro. Purified ClpXP slowly degraded FlhC and FlhD
subunits (Fig. 1a). In vitro degradation with purified FliT
showed that it enhanced the ClpXP-dependent degradation of
FlhC subunit but not the FlhD subunit in FlhD4C2 (Fig. 1a). In
the absence of ATP, both FlhC and FlhD subunits remained
undegraded, suggesting that the enhancement effect of FliT is
linked to ATPase activity of ClpX. When ClpXP was removed
from this reaction, degradation of FlhD4C2 did not occur (data
not shown), excluding the possibilities that FliT also possesses
protease activity and that proteases contaminate the purified
FliT fraction. The effect of FliT on degradation of individual
FlhC by ClpXP in vitro was not determined because the FlhC
subunit could not be purified as a soluble protein, whereas FlhC
could be purified when complexed in FlhD4C2. Purification of
individual FlhC has so far not been successful (27, 28).
In vitro degradation assays, using purified FlhD4C2 complex
whose FlhC subunit was His6-tagged at the N terminus, were
also done to test the effect of N-terminal tagging of FlhC (Fig.
1b). ClpXP-dependent degradation of the FlhC subunit of this
His-tagged FlhD4C2 complex was stimulated in the presence of
FliT to the same extent as intact FlhC (Fig. 1, a–c). Hence,
tagging the N terminus of FlhC subunit does not affect the
function of FliT in enhancing ClpXP-dependent FlhC degrada-
tion. This His-tagged version of FlhD4-(His6FlhC)2 was there-
fore used for subsequent analyses. To check the effect of ADP
that is generated during the reaction and inhibits the activity of
ClpX, an in vitro degradation assay under regeneration condi-
tion was also performed by adding creatine kinase and creatine
phosphate into the reaction. A consistent result was obtained in
the degradation assay by the regeneration system, as expected
from the clear difference of FlhC degradation between FliT()
and FliT() at the early time point of reaction (15 min),
where the generated ADP is negligible (data not shown).
N-terminal Domain of ClpX Is Required for Enhancement
Effect of FliT on FlhC Degradation—ClpX unfolds proteins and
presents them to ClpP for degradation. A zinc-binding domain
(ZBD) at theN terminus ofClpX is proposed to play a role in the
recognition of substrates destined for degradation (20, 29, 30).
We asked whether the ZBD domain of ClpX is required for the
enhancing effect of FliT on ClpXP proteolysis of FlhC by an in
TABLE 3












clpX 2495.0 107.4 31.1 6.3 0.012
clpX 3022.5 268.4 357.0 16.1 0.118
clpX1–60 3146.4 163.0 350.2 12.6 0.111
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vitro degradation assay with the ZBD-depleted mutant ClpX.
Removal of the N-terminal domain (deletion of amino acids
1–60) of ClpX completely abolished the enhancement of
ClpXP-catalyzed proteolysis of FlhC by FliT (Fig. 2, a and b).
The ZBD mutant of Salmonella ClpX used in this study could
rapidly degrade the model substrate, GFP-SsrA (data not
shown), as in E. coli ClpX (20). The requirement of the ZBD
domain of ClpX for the inhibitory effect of FliT was also exam-
ined in a strain overexpressing the fliT gene under the control
of ParaBAD. Depletion of the ZBD domain of ClpX partially sup-
pressed the inhibitory effect of the overproduction of FliT on
fliL transcription to the same extent as complete deletion of
ClpX (Table 3). These results suggest that the N-terminal ZBD
of ClpX is essential for the enhancement of ClpXP proteolysis
of FlhC by FliT.
FliT Acts Efficiently and Specifically—Most of enhancement
factors for AAA proteases are recycled during enhancement
of the degradation of target substrate by protease, whereas
some of the enhancement factors are degraded together with
the target substrate by protease, such asVir (31) andMecA (32);
thus, a stoichiometric amount is required for an efficient
enhancement reaction. To reveal in which way FliT acts, we
examined whether FliT is recycled in the enhancement reac-
tion. In vitro degradation assays using four different concentra-
tions of FliTs showed that only 0.02 M FliT2 sufficiently
enhanced the degradation of a 100-fold molar excess of FlhC
relative to FliT (Fig. 2, c and d). At a time of 10 min, about 30%
of FlhC degradation was enhanced, corresponding to enhance-
ment of 0.6 M FlhC degradation by 0.02 M FliT2 (30-fold
molar excess). Moreover, the effect of FliT2 was almost satu-
rated around 1 M. These results suggest that FliT is recycled
during enhancement of FlhC degradation, and only a small
amount of FliT relative to FlhD4C2 is required for efficient
enhancement of FlhC degradation.
FIGURE 1.Degradation of FlhC in FlhD4C2 by ClpXP is accelerated by FliT in vitro. Effect of FliT on the ClpXP-dependent degradation of the FlhD4C2 (a) and
FlhD4-(His6FlhC)2 (b) was examined. Each sample of 0.75M FlhD4C2 was preincubated for 3min in the presence or absence of 1.0M FliT2 andmixedwith 0.2
MClpX6ClpP14 and0or 3mMATP to start theproteolysis. Sampleswere taken at the indicated times. Eachproteinwas separated in a 16%SDS-polyacrylamide
gel and was detected by Coomassie Brilliant Blue staining. c, quantification of the FlhD and FlhC relative to the value at time 0 in the degradation assay using
FlhD4-(His6FlhC)2. Mean and S.D. values (error bars) of the results of triplicate independent experiments are given. Triangles and squares show the band
intensities of FlhD and FlhC, respectively. The solid line and the dashed line show the data of FliT() and FliT(), respectively. The band intensity of ClpX in each
lanewas used for the internal control.
FliT Enhances a ClpXP-catalyzed Proteolysis of FlhC
NOVEMBER 21, 2014•VOLUME 289•NUMBER 47 JOURNAL OF BIOLOGICAL CHEMISTRY 33005











To determine whether FliT is a specific enhancement factor
for FlhC, in vitro degradation was assayed using purified model
substrates, GFP-SsrA and LambdaO. Whether in the presence
or absence of FliT,His6GFP-SsrA andLambdaOwere degraded
at similar rates (Fig. 3, a and b). As shown in the degradation of
the FlhD4C2 complex (Fig. 1, b and c), degradation of the FlhD
subunit was unaffected by the presence of FliT. These results
suggest that FliT works specifically on FlhC, based on the spe-
cific interaction between FlhC and FliT rather than as a general
enhancement factor promoting chaperone activity of ATPase
subunit, like MecA for ClpC (33), or promoting the protease
activity of ClpP (34).
FliT, FlhD4C2, and ClpX Form Ternary Complex in Vitro—
To understand the mechanism of action of FliT on FlhD4C2
degradation, interaction between FliT and ClpX was assayed.
Previously known adaptors enhancing the degradation of
ClpXP substrates, such as SspB and UmuD, act as a tethering
mechanism. In this way, an adaptor interacts stronglywith both
the cognate substrate and ClpX tomediate a tighter interaction
betweenClpX and the substrate. BecauseZBD is involved in the
enhancing effect of FliT (Fig. 2a), it was assumed that ZBD
directly interacts with FliT. BLI analysis allowed us to investi-
gate the interaction between ClpX and FliT. LambdaO, known
as a ZBD-binding protein (35), bound directly with ZBD in a
concentration-dependent manner (data not shown). In con-
trast, there was no interaction between FliT and ZBDunder the
same condition. To examine the interaction between FliT and
ClpX further, we also performed an in vitro pull-down assay
using GST-tagged FliT. As reported previously, binary interac-
tion between GST-FliT and FlhD4C2 was detected by the pull-
down assay (Fig. 4a, lanes 1–3). No direct interaction between
FliT and ClpX could be detected (Fig. 4a, lanes 4–6). On the
other hand, preincubation of ClpX, GST-FliT, and FlhD4-
(His6FlhC)2 generated a ternary complex of the three compo-
FIGURE 2. Effect of FliT to enhance in vitro degradation of FlhC requires
N-terminal zinc binding domain of ClpX, and a very small amount of FliT
efficiently enhances thedegradationof FlhC. Thedegradation assay using
N-terminal zinc-binding domain-depleted mutant ClpX was performed as
described in the legend to Fig. 1. The level of FlhC during degradation assay is
shown in a, and the quantification of the band intensity of FlhC is shown in b.
Mean and S.D. values (error bars) of triplicate independent experiments are
shown. The solid lines and the dashed lines show the data of FliT() and
FliT(), respectively. Squares and circles show the data of wild type ClpX and
ZBD-ClpX, respectively. Degradation of 1.0M FlhD4C2 by 0.2MClpXPwas
examined in the presence of four different concentrations of FliT2 (0, 0.02, 1.0,
and 3.0 M) in the degradation assay, as shown in c. The level of FlhC during
the degradation assay is shown. Quantification of FlhC relative to the value at
time 0 in the degradation assay is shown in d. Diamonds, squares, triangles,
and circles show the data of 0, 0.02, 1.0, and 3.0 M, respectively. Mean and
S.D. values of triplicate independent experiments are given. 0.02 M FliT2 is
sufficient to enhance the degradation of 2.0 M FlhC by 0.2 M ClpX6ClpP14.
FIGURE 3. Effect of FliT on ClpXP-catalyzed proteolysis of GFP-SsrA and of LambdaO in vitro.Degradation of 1.5M GFP-SsrA (a) and LambdaO (b) in the
presence or absence of 1M FliT2 was assayed. The same reaction buffer with the FlhD4C2 degradation assaywas used. Mean and S.D. values (error bars) of the
results of triplicate independent experiments for GFP-SsrA and LambdaO are given in c and d, respectively.
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nents (Fig. 4, a (lanes 7–9) and b). When purified GST instead
of GST-FliTwas incubated with ClpX and FlhD4C2, no ClpX or
FlhDor FlhCwas detected (Fig. 4, a (lanes 10–12) and b), which
suggests that FliT mediates the formation of the ternary com-
plex with ClpX and FlhD4C2. Whereas FliT stimulated ATPase
activity of ClpX in the presence of FlhD4-(His6FlhC)2 and ClpP
(Fig. 5, p 	 0.01, Student’s t test), there was no stimulation in
the absence of FlhD4-(His6FlhC)2. The data also suggest that
FliT does not directly interact with ClpX but does so with FlhC,
forming a FliT-FlhD4C2-ClpX ternary complex.
Binding of FlhD4C2 toClpX Is Promoted by FliT—The forma-
tion of a ternary complex of FliT-FlhD4C2-ClpX (Fig. 4) sug-
gests that the enhancing effect of FliT is exerted by a step-
wise mechanism rather than a simple tethering mechanism,
as follows: (i) binding of FliT to FlhD4C2 complex, (ii) alter-
ation of the accessibility of the recognition region on FlhC,
and thereby (iii) increase of the affinity between ClpX and
FlhD4C2. To test this hypothesis, the binding between ClpX
and FlhD4-(His6FlhC)2 complex was assessed by an in vitro
pull-down assay using Ni-NTA-agarose beads. Coeluted
ClpX bound to His-tagged FlhD4C2 complex in the presence
or the absence of FliT was examined. In the presence of FliT,
binding of ClpX to FlhD4C2 complex increased (Fig. 6, a and
b, p 	 0.01, Student’s t test), suggesting that the affinity
between ClpX and FlhD4C2 complex is promoted by FliT. A
pull-down assay using a different FlhD4C2 protein with a His
tag at the N terminus of FlhD also promoted interaction
FIGURE 4.Detection of ternary complex of GST-FliT-ClpX-FlhD4C2 by in vitro pull-down assay. 1 M purified (GST-FliT)2 was batch-bound to GST resin in
100l of Clp assay buffer containing 1mMATPS. The (GST-FliT)2 was incubatedwith 0.1MClpX6 and 1M FlhD4-(His6FlhC)2 for 5min. GST resinwaswashed
twice by 500l of Clp assay buffer. ClpX and FlhD4-(His6FlhC)2 bound to GST-FliT were coelutedwith 100mMGSH-containing Clp assay buffer. Input (IN), wash
(W), and elution (E) fractionswere loaded onto the SDS-PAGE gel as shown in a. Mean and S.D. values (error bars) of the band intensities of ClpX estimated from
triplicate independent experiments are given in b.
FIGURE 5. FliT promotes the ATPase activity of ClpX in the presence of
FlhD4C2. ATPase activity of ClpX (0.5 g) was measured in the absence or
presence of FliT (0.5 g), ClpP (0.5 g), and/or FlhD4-(His6FlhC)2 (2.0 g).
Mean and S.D. values (error bars) were estimated from at least three inde-
pendent experiments.
FIGURE 6. FliT promotes the binding between ClpX and FlhD4C2. 1.0 M
purified N terminally His-tagged FlhD4C2was batch-bound to Ni-NTA resin in
100l of Clp assay buffer with 10mM imidazole. 1M FliT2 was preincubated
with FlhD4-(His6FlhC)2 for 5min. Boundbeadswerewashed twice in 500l of
Clp assay buffer. ClpX and FliT bound to FlhD4-(His6FlhC)2were coelutedwith
500 mM imidazole-containing Clp assay buffer. Input (IN), wash (W), and
elution (E) fractions were loaded on the SDS-PAGE gel as shown in a. Quanti-
fication of the ClpX coeluted with FlhD4C2 is shown in b. The result of quanti-
fication for the pull-down assay using the non-hydrolyzable ATP analog
AMP-PNP is also shown inb. ClpXband intensitywas normalizedby the inten-
sity of eluted FlhC in the same lane. *, statistical significance of the difference
between FliT and FliT (p	 0.01, Student’s t test). Themean and S.D. values
(error bars) were estimated from triplicate independent experiments.
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between FlhC and ClpX (data not shown), confirming that
there was no effect of His tagging at the N terminus of FlhC
on FlhC-ClpX interaction.
To distinguish whether FliT enhances the recognition of
FlhD4C2 complex by ClpX and/or promotes the unfolding of
FlhD4C2 complex requiring ATPase activity of ClpX, a pull-
down assay was performed with a non-hydrolyzable ATP ana-
log, AMP-PNP. Increased affinity between ClpX and FlhD4C2
complex by FliT was also obtained with AMP-PNP (Fig. 6b).
Thus, the FliT effect works at a very early stage of substrate
processing by ClpX that does not require ATPase activity.
FlhD4C2 Is Protected from Degradation by ClpXP When
Bound to Class II Promoter DNA—FlhD4C2 is a DNA-binding
protein that strongly binds to the class II promoter region. To
determine whether the FliT-ClpXP system degrades FlhD4C2
bound to the promoter DNA, interaction between flhB pro-
moter DNA and His-tagged FlhD4-(His6FlhC)2 was initially
assessed by the BLI method. Sensor responses for FlhD4C2-
DNA interaction showed concentration dependence, with
responses reaching a plateau around maximum concentration
(Fig. 7a), indicating a specific interaction between FlhD4-
(His6FlhC)2 and DNA (Fig. 7a). Control unrelated DNA frag-
ments showed only faint or almost no interaction with FlhD4-
(His6FlhC)2 (Fig. 7b).Kd of 2.1 1.0 nM and t1⁄2 of 12.8min 4.8
(decay of FlhD4C2-DNA complex) were estimated from the
sensorgrams of triplicate independent BLI assays. Hence, puri-
fied FlhD4C2 strongly binds with flhB promoter DNA and dis-
sociates slowly under the conditions of the degradation assay.
In examining the effect of DNA on the degradation of
FlhD4C2 by ClpXP in the presence of DNA (Fig. 7, c and d), it
strongly inhibited the degradation of FlhC and FlhD, suggesting
that the DNA-bound form of FlhD4C2 is resistant to proteoly-
sis. Control DNA fragment unbound to FlhD4C2 did not affect
the degradation of FlhD4C2, suggesting that this inhibition is
due to specific interaction between FlhD4C2 and its binding site
on class II promoter DNA. On the other hand, when 1M FliT2
was given before the addition of DNA, FlhC was rapidly
degraded by ClpXP, from which we can infer that inhibition of
the FlhD4C2-DNA interaction by FliT has an additional impor-
tant role in the ClpXP-dependent pathway of FliT inhibition;
FliT increases the proteolytically sensitive form of free
FlhD4C2, which is preferentially degraded by ClpXP. If FliT was
incubated after the addition of DNA, the inhibition of FlhC
degradation by DNA was partially suppressed (Fig. 7, c and d).
This suggests that once FlhD4C2 binds to DNA, interaction
between FliT and FlhD4C2 is decreased due to the hindered
access to the interaction site of FliT on FlhD4C2, consistent
with the surface plasmon resonance experiments byAldridge et
al. (36). Remaining enhancement of FlhC degradation com-
pared with the FliT()/flhB promoter DNA() reaction sug-
gests that FlhD4C2 released from DNA during the degradation
assay is rapidly captured by FliT and delivered toClpXP-depen-
dent proteolysis.
DISCUSSION
Mechanism of Enhancement of ClpXP-dependent Degrada-
tion of FlhC by FliT—Several mechanisms that enhance sub-
strate degradation by AAA proteases have been proposed.
These include the induction of subcellular co-localization of a
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FIGURE7.DNA-bound formof FlhD4C2 is resistant toproteolysis.a, sensorgrams in theBLI interaction assaybetween FlhD4-(His6FlhC)2 capturedonNi-NTA
sensor chip and flhB promoter DNA. DNA concentrations used in the assay are shown. b, sensorgrams in the BLI interaction assay between FlhD4-(His6FlhC)2
captured on Ni-NTA sensor chip and control unrelated DNA fragment. c, degradation assay of FlhD4-(His6FlhC)2 by ClpXP in the presence or absence of FliT
and/or DNA. 1M FliT2, 0.75M flhB promoter DNA, or 0.75M control DNAwasmixed with 0.75M FlhD4-(His6FlhC)2 as indicated and incubated for 3min at
37 °C. 1M FliT2 or 0.75M flhB promoter DNA and 0.2MClpX6P14 were added as indicated and incubated for 5min. FliT3DNA andDNA3 FliT, the addition
of FliT before DNA incubation and DNA before FliT incubation, respectively. ATP (3 mM) was added to start proteolysis. Each protein was separated in a 16%
SDS-polyacrylamide gel and was detected by Coomassie Brilliant Blue staining. d, mean and S.D. values (error bars) of the FlhC band intensity estimated from
the results of triplicate independent experiments are given. Solid lines with circle, square, and triangle symbols indicate the FliT() assays of no DNA, flhB
promoter DNA, and control DNA, respectively. Dashed lines with asterisk and diamond symbols indicate the FliT() assays of DNA3 FliT and FliT3 DNA,
respectively.
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affinity by adaptor molecules (6, 7), and enhancement of pepti-
dase activity of ClpP by ADEP (34). We have shown that FliT
selectively enhances FlhC degradation by adaptor-like mecha-
nisms, through ternary complex formation of FliT-ClpX-
FlhD4C2 and promotion of ClpX-FlhD4C2 interaction (Figs. 4,
6, and 8). However, the action of FliT was different from those
of representativeClpX adaptors, such as SspB andUmuD; these
adaptors enhance substrate degradation by a so-called tether-
ing mechanism. The adaptor itself in the mechanism directly
interacts withN-domain of ClpX and promotesClpX-substrate
interaction. FliT did not directly interact with ClpX, suggesting
different mechanisms. Several adaptor-like factors are known
to enhance substrate degradation without directly interacting
with ClpX (37, 38). For example, degradation of the Mu Rep
protein is enhanced by Vir, which does not interact directly
with ClpX. Binding of Vir to Rep substrate leads to a conforma-
tional change of Rep degron, resulting in enhanced degradation
of Rep (38). FliT also increased the interaction between ClpX
and FlhD4C2, making affinity promotion by local conforma-
tional change possible for the FliT-ClpXP system. Conforma-
tional change or oligomeric state affects the susceptibility to
AAA proteases; for example, polymerized FtsZ interacts with
ClpX more tightly than the monomeric state (39, 40). Tight
recognition and disassembly of only one protomer in the MuA
tetramer by ClpX is also an example of conformation-depen-
dent control of substrate recognition (41). Elucidation of the
mechanismof an enhanced interaction between FlhC andClpX
from the structural viewpoint is an on-going project in our
laboratory.
Degradation of FlhC Subunit in FlhD4C2 Complex Is Selec-
tively Enhanced by FliT—The FliT effect of enhancing the deg-
radation by ClpXP was found only for the FlhC subunit in the
FlhD4C2 complex (Fig. 1), despite FliT promoting the binding
of ClpX to FlhD4C2 (Fig. 6). The lack of direct interaction of
ClpX with FliT and the fact that FliT interacts only with FlhC,
but not with FlhD (17), suggest that FliT binding to FlhD4C2
specifically affects the FlhC subunit andClpX-FlhC interaction.
Considering the previously proposedmodel that ClpX does not
recognize the substrate without degron (5), along with our
observation that ClpXP degrades both subunits of the FlhD4C2
complex (Fig. 1), it seems that both subunits of the FlhD4C2
complex have their own individual degrons. Hence, it is of
interest that ClpX-FlhD4C2 interaction is promoted by FliT,
but only FlhC is enhanced. Degradation rates of FlhD and FlhC
in vitro differ substantially (Fig. 1), suggesting that degradation
of both subunits in the FlhD4C2 complex does not proceed
simultaneously. Therefore, the individual subunits in FlhD4C2
are likely to be independently recognized and processed by
ClpXP. Dissociation of the FlhD subunit from FlhC-FliT-
ClpXP ternary complex during processing of FlhC subunit is
probably the reason that it has no effect on FlhD degradation in
the presence of FliT. Interestingly, in contrast to FliT, YdiV
interacts with FlhD subunit in FlhD4C2 (42), but it enhanced
ClpXP-dependent proteolysis of both subunits, FlhC and FlhD,
of FlhD4C2 (12). Rapid degradation of the FlhD subunit in the
FlhD4C2 could generate unstable dissociated individual FlhC
and cause drastic conformational change to FlhC, which may
lead to its enhanced proteolysis.
FlhD and FlhC exist as two forms in the cell, FlhD2 and
FlhD4C2 (43). For efficient binding of FlhD4C2 to class II pro-
moter DNA, both subunits of FlhD4C2 are required (44), sug-
gesting that enhanced degradation of only the FlhC subunit is
sufficient to control FlhD4C2 activity. The fact that FlhD2 also
has a DNA binding ability (43) indicates its distinctive role and
suggests that selective enhancement of FlhCdegradation has an
additional effect other than decreasing FlhD4C2 activity. FlhD2
also has roles in stabilizing FlhC and promoting the DNA bind-
ing ability of FlhC by forming stable hetero-oligomer FlhD4C2.
Thus, the cellular pool of individual FlhD2might affect FlhD4C2
activity and support rapid construction of active FlhD4C2 when
cells require flagella. Enhancement of FlhC degradation by
FliT-ClpXP may be involved in adjusting the cellular pool of
FlhD2.
Multiple Degradation Enhancement Factors for FlhD4C2—
We found a second factor that enhances FlhD4C2 degradation
in addition to YdiV. Intriguingly, the ClpXP-dependent effect
of FliT in vivowas stronger than that of YdiV (data not shown),
suggesting that both work on the ClpXP-dependent pathway
but in dissimilar ways. The two factors interact with different
partners; YdiV interacts with FlhD, whereas FliT interacts with
FIGURE 8.Model of ClpXP-dependent FliT inhibition of FlhD4C2 activity.
In this study, we revealed two novel ClpXP-dependent routes of FliT effect in
inhibiting FlhD4C2 activity. i, the inhibition of DNA binding of FlhD4C2 by FliT
increases the free form of DNA-unbound FlhD4C2 sensitive to ClpXP-depen-
dent proteolysis, thus leading to enhanced degradation of FlhD4C2. ii, FliT
binding to FlhC subunit of FlhD4C2 promotes FliT-FlhD4C2-ClpXP ternary
complex formation and enhances selective degradation of FlhC subunit of
FlhD4C2. FliT is a flagellum-related gene whose transcription is regulated by
both class II and class III promoters. Therefore, concerted action of FliT and
ClpXP is considered tobe important for the stringent control of FlhD4C2 activ-
ity in a manner of negative feedback control.
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the FlhC subunit in FlhD4C2. Another notable difference
relates to the DNA binding state of FlhD4C2. We previously
showed that YdiV stripped off FlhD4C2 that was prebound to
DNA (12). On the other hand, FliT could not interact with
FlhD4C2 prebound to DNA (36). ClpXP moderately degrades
both subunits of FlhD4C2 even without FliT; however, the
DNA-bound form of FlhD4C2 becomes insensitive to proteoly-
sis by ClpXP (Fig. 7). Furthermore, the FlhD4C2-DNA complex
is very stable, as shown from the slow dissociation of FlhD4C2
from FlhD4C2-DNA complex (t1⁄2 
 12.8 min from our BLI
assay and 40 min as reported by Claret and Hughes (43)).
These results suggest that control of FlhD4C2 activity by FliT or
ClpXP is mostly restricted by the state of the DNA-unbound
free form of FlhD4C2. The FliT effect, shifting the equilibrium
from the DNA-bound to the DNA-unbound form by inhibiting
DNA binding of FlhD4C2, may have an additional role in the
ClpXP-dependent pathway (i.e. increasing the amount of rec-
ognizable FlhD and FlhC in FlhD4C2, which leads to the
enhanced proteolysis by ClpXP) (Fig. 8).
In E. coli, multiple anti-adaptors for RssB are expressed to
control RpoS levels in multiple modes when cells adapt to the
different stresses (e.g. anti-adaptors IraM and IraP are up-reg-
ulated for protecting RpoS from rapid degradation by RssB in
response to magnesium and phosphate deprivation, respec-
tively) (45). Such multiple adaptor-related factors present a
rational strategy for the bacteria to respond to different
stresses. In the case of the control of FlhD4C2, FliT and YdiV
seem to have distinct roles and have different timings, consid-
ering that expression of YdiV only occurs when Salmonella
encounter nutrient poor conditions (10). YdiV may have an
important role in shutting off flagellar biogenesis insidemacro-
phage and evading the host immune system (46). For such pur-
poses, YdiV ought to completely inhibit FlhD4C2 activity; to
accomplish a complete shut-off, YdiV acts even on the DNA-
bound form of FlhD4C2 (i.e. on all states of FlhD4C2). In con-
trast, FliT expression is regulated by flagellar class II and III
promoters (i.e. downstream of flhDC). Hence, accelerated FlhC
degradation by FliT-ClpXP is assumed to be important in con-
trolling the number of flagella by a negative feedback mecha-
nism. Salmonella depleted of fliT have more flagella irrespec-
tive of the nutrient levels in the culture media (36). Aldridge et
al. (36) showed that overexpression of FliT could not com-
pletely abolish the basal level of flagellar expression. Consistent
with these results, our data show that the effect of FliT-ClpXP
regulation is maximum on the free DNA-unbound FlhD4C2
(Fig. 7) (i.e. theDNA-bound state of FlhD4C2 becomes resistant
to FliT and to ClpXP). This moderate negative regulation
dependent on the DNA binding state of FlhD4C2 may contrib-
ute to the retention of a basal level of flagellar expression in
order to construct a substantial number of flagella or work as a
buffer to respond rapidly to external stimuli favoring the flag-
ellated state, as in the model proposed by Aldridge et al. (36).
The insensitivity ofDNA-boundFlhD4C2 to FliT inhibition and
the long half-life of DNA-bound FlhD4C2 indicate the impor-
tance of the stringent control of the cellular level of the free
form of FlhD4C2 in the regulation of flagellar biogenesis. The
fact that only a very small amount of FliT sufficiently enhanced
ClpXP-dependent degradation of FlhC (Fig. 2, c and d) suggests
the relative impact and efficacy of the ClpXP pathway com-
pared with the stoichiometric action of FliT alone inhibiting
DNA binding of FlhD4C2. From these results, the ClpXP path-
way of the FliT-dependent anti-FlhD4C2 effect can be consid-
ered as having a substantial role in the negative feedback loop
that controls flagellar biogenesis.
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